| Scott Thomas, | |
|
4240 Yellowstone Ave, Chubbuck, ID 83202-2420 | |
| (208) 237-5091 | |
| (208) 237-6897 |
| Full Name | Scott Thomas |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4240 Yellowstone Ave, Chubbuck, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558770693 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P6659 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Scott Thomas, 4240 Yellowstone Ave, Chubbuck, ID 83202-2420 Ph: () - | Scott Thomas, 4240 Yellowstone Ave, Chubbuck, ID 83202-2420 Ph: (208) 237-5091 |
News Archive
Subclinical hyperthyroidism is not associated with overall or cardiovascular mortality, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
Abiogen Pharma S.p.A. of Pisa Italy and Lee's Pharm jointly announced the agreement for License, Distribution and Supply for marketing of Attila® (Neridronic Acid) throughout China, Hong Kong, Macau and Taiwan.
A Texas court case reveals gaps in physician oversight, The New York Times reports. "It was beyond [Anne Mitchell's] conception that she would be indicted and threatened with 10 years in prison for doing what she knew a nurse must: inform state regulators that a doctor at her rural hospital was practicing bad medicine." Mitchell was first jailed in June and will stand trial this week for "misuse of official information, a third-degree felony in Texas," after reporting a physician for using unorthodox procedures - some of which went awry - and practicing in an operating room where he did not have privileges.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B/2 dose-ranging clinical study with its anticoagulant reversing agent, PMX-60056. The study is intended to demonstrate the safety and efficacy of PMX-60056 in reversing varying heparin levels, including the highest levels commonly used in surgical settings.
A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor, which is responsible for removing the bad cholesterol (LDL-cholesterol) from the bloodstream, may be inhibited by a third protein, annexin A2.
› Verified 9 days ago
Stephen C Schiers, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4215 Yellowstone Ave, Chubbuck, ID 83202 Phone: 208-237-6828 | |
Steven Haack, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4257 Yellowstone Ave, Chubbuck, ID 83202 Phone: 208-237-3940 Fax: 208-237-9257 | |
Clint L Jensen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4845 Chubbuck Ave, Chubbuck, ID 83202 Phone: 208-237-3900 Fax: 208-237-4955 | |
John Cole Warburton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4845 Yellowstone Ave, Chubbuck, ID 83202 Phone: 208-237-3900 Fax: 208-237-4955 | |
Robert Newsom, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4257 Yellowstone Ave, Chubbuck, ID 83202 Phone: 208-237-3940 | |
Mrs. Aime Taylor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4215 Yellowstone Ave, Chubbuck, ID 83202 Phone: 208-237-6828 Fax: 208-238-8371 | |
Melanie Prescott, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 880 W Quinn Rd, Chubbuck, ID 83202 Phone: 208-238-2000 |